A new urine test, MyProstateScore 2.0 (MPS2), can now detect aggressive prostate cancer with 94 per cent accuracy—no hospital visit required. This at-home test identifies high-risk cases, reducing unnecessary biopsies.

Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancerscreeningis highly accurate. The exciting new results, published in The Journal of Urology, build upon a prior Vanderbilt study of prostate cancer screening that required a digital rectal exam.